Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Beth Israel Medical Center
Patients with Fibromyalgia will show elevated ventricular lactate levels as measured via magnetic resonance spectroscopy (MRS). Patients treated with Milnacipran will show normalization of ventricular lactate levels compared to those treated with placebo, and will also show normalization of the increased latency to respond to complex reaction time probes compared to those treated with placebo.
Age
18–68
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female or male subjects who fulfill the American College of Rheumatology's case definition for Fibromyalgia.
18 through 68 years of age
You may not be if
Pregnant or trying to become pregnant
Taking any other Serotonin Norepinephrine Reuptake Inhibitor (SNRI) or already taking milnacipran
Patients who do not indicate their pain levels as less than substantial despite their best care
History of any psychotic disorder or history of alcoholism or drug abuse within 10 years of intake as determined by psychiatric diagnostic interview
Presence of current depression as determined by psychiatric diagnostic interview